Core Viewpoint - The successful completion of Dongguan's first domestic Longjing PR intraocular lens implantation surgery marks a significant breakthrough in refractive correction technology in the region, providing more medical options for myopia patients [1]. Group 1: Surgical Details - The surgery was performed by Chen Xiaobei, the director of the refractive surgery department, who has over 8,000 cases of intraocular lens surgeries experience [1]. - The Longjing PR lens, approved for market in January 2025, is the first ciliary groove-fixated artificial lens in China, filling a domestic technology gap and providing a new solution for myopia patients with degrees ranging from 325 to 1800 [1]. Group 2: Patient Experience - The first beneficiary of the surgery, a 35-year-old professional named Xiao, had over 600 degrees of myopia and chose the lens implantation due to its non-invasive nature and strong reversibility, expressing confidence in the surgical outcome [1]. Group 3: Industry Context - The advancement in domestic medical technology is emphasized by the statement from Chen Xiaobei, highlighting the importance of integrating international advanced technology while accumulating local experience for the benefit of Dongguan patients [2]. - The first ICL implantation surgery in Dongguan was completed in April 2015, marking the beginning of the "additive correction" era, with the recent Longjing lens surgery representing a decade of progress in the field [2].